Home > Insider Trading > Teva Pharmaceutical Industries Ltd

Teva Pharmaceutical Industries Ltd (TEVA)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
111 - 120
Next >>

AstraZeneca PLC (ADR) (AZN), Ranbaxy Laboratories Limited (ADR) (RBXLY) Wins Over Illegal Deal Case

The 1st US Circuit Court of Appeals has recently ruled in favor of AstraZeneca plc (ADR) (NYSE:AZN) and Ranbaxy Laboratories Limited (ADR) (OTCMKTS:RBXLY) on a long-lasting class action lawsuit involving...

Keep Reading →

November 23rd, 2016 - News Stock Analysis

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) May Settle Bribery Allegations For $520 Million

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is alleged to have bought its way into boosting its sales in foreign countries including Russia, Mexico, and Ukraine.

Keep Reading →

November 16th, 2016 - News Stock Analysis

Here's Why Investors Are Buzzing about Teva, Amazon, Exxon, and Two Other Stocks

It seems like Deja Vu all over again as pollsters and conventional wisdom were again proven wrong.

Keep Reading →

November 9th, 2016 - Market Movers News

Here's Why ENSCO PLC (ESV), Yum! Brands, Inc. (YUM), and Three Other Stocks Are Trending Today

In this article, let's examine why ENSCO PLC (NYSE:ESV), Yum! Brands, Inc.

Keep Reading →

November 4th, 2016 - Market Movers News

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Requests Stricter Approval Requirements For Copaxone Generics

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) will have to wait for a court ruling over its IP protection for its lifelong multiple sclerosis therapy, Copaxone.

Keep Reading →

November 1st, 2016 - News

Why Toyota, IBM, Teva, and Two Other Stocks Are in Spotlight Today

Among the stocks that traders are watching are Toyota Motor Corp (ADR) (NYSE:TM), Martin Marietta Materials, Inc.

Keep Reading →

October 26th, 2016 - Market Movers News

Is Teva Pharmaceutical Industries Ltd (TEVA) Planning Celltrion Takeover To Bolster Biosimilar Portfolio?

Reports in the pharmaceutical space indicate that Teva Pharmaceutical Industries Ltd (NYSE:TEVA) might be planning to acquire South Korea biosimilar giant Celltrion.

Keep Reading →

October 19th, 2016 - News Stock Analysis